Research programme: flavivirus vaccines - Crucell/WRAIR
Latest Information Update: 16 Jun 2011
At a glance
- Originator Crucell; Walter Reed Army Institute of Research
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Dengue; Encephalitis virus infections
Most Recent Events
- 13 Apr 2006 Preclinical trials in Dengue in USA (unspecified route)
- 13 Apr 2006 Preclinical trials in Encephalitis virus infections in USA (unspecified route)